Topics

LexaGene Holdings sees path to sales through multiple uses of technology

11:08 EDT 1 May 2019 | Proactive Investors

LexaGene Holdings (CVE:LXG) CEO and Co-Founder Dr. Jack Regan joined Steve Darling from the Toronto studio of Proactive to talk about their technology that is being used in multiple ways. From dogs to E-coli, Regan talked about how their machine can be a major help.

Regan also telling Proactive what the next year looks like for the company as they ramp up their sales teams and look at different sectors. 

Original Article: LexaGene Holdings sees path to sales through multiple uses of technology

NEXT ARTICLE

More From BioPortfolio on "LexaGene Holdings sees path to sales through multiple uses of technology"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...